Bioheart (OTC: BHRT; Twitter: $BHRT)

LifeTech Capital Updates NeoStem (NBS) Strong Buy $4.00 Target

The ProActive Network's PRISM product

FDA Phase III Approval Historical Stock Performance

DARA Bio ($DARA) - KRN5500 article from the Journal of Pain and Symptom Management International

Lazard Capital Markets Research Report on Ventrus Biosciences (NASDAQ: VTUS; Stock Twits; $VTUS)

Leerink Swann Research Report on Ventrus Bio ($VTUS)

UniLife Corporation (NASDAQ: UNIS) @ Cowan

Unilife ($UNIS) - Jefferies Healthcare Conference

Unilife ($UNIS) Investor Presentation - July 2011

Medgenics (NYSE AMEX: MDGN) - Nomura Code Securities Limited, London

Griffin Securities reiterates Unilife Corp ($UNIS) target with $10.50 target

Tonix Presentation November 2011

Unilife ($UNIS) - Prefilled Syringes Issue of OnDrugDelivery

Unilife Corp ($UNIS) - Innovative Drug Delivery Device Solutions

Misonix (NASDAQ: MSON) Technology and Growth Status Report - May 2011

Vringo Presentation

Rodman & Renshaw - $VTUS May 2011 Update

Medgenics (NYSE AMEX: MDGN) - Maxim Group Research Report

Ensurge, Inc. (OTCBB: ESGI; Twitter: $ESGI)